NEW YORK, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Applied UV, Inc. (NASDAQ: AUVI), a leader in global food security, air quality, and intelligent building solutions today announced its financial results for the second quarter 2022. For the quarter, revenues were $10.8 million, increasing 83.6%, compared with $5.9 million in the second quarter of 2022. Gross profit for the second quarter of 2023 increased to $2.4 million, up 84.8%, compared with $1.3 million in the second quarter of 2022.
Q2 2023 and Recent Business Highlights
“We believe the continued increase in our customer commitments to engage Applied UV as their trusted resource across all of our businesses supports our long-term growth strategy. The expansion of our backlog also reflects the success we are experiencing in winning new customers nationwide,” said Max Munn, CEO of Applied UV. “We believe our robust growth in backlog, together with our strategic acquisitions, provides a positive outlook for the remainder of this year and that our strategies for profitable growth in 2024 and beyond are gaining momentum.”
Brian Stern, President of Puro Lighting, commented, “The second quarter has been a truly significant period for the Intelligent Building Solutions division of Applied UV Inc., marked by our selection for the General Services Administration GPG Competition, our pioneering research partnership on Far UV with Johnson Controls and USHIO, and expanded growth in the multifamily sector. Our continued advancements in technologies to enhance food security and produce shelf life, coupled with sales synergies and expense improvements across divisions, demonstrate our drive towards innovation and increased operating efficiency. These collective achievements represent our commitment to enhancing shareholder value, as we continue to lead in sustainable and intelligent building solutions.”
Q2 2023 Summary Financial Results
Net Sales
Net sales of $10.8 million represented an increase of $4.9 million, or 83.6% for the three months ended June 30, 2023, as compared to net sales of $5.9 million for the three months ended June 30, 2022. The Disinfection/Healthy Building Technologies segment increased $4.0 million, primarily due to the acquisition of Puro Lighting and LED Supply Co. on January 26, 2023. Additionally, the Hospitality segment increased $0.9 million as that market is steadily improving.
Gross Profit
Gross profit increased $1.1 million, or 84.8%, to $2.4 million for the three months ended June 30, 2023, as compared to $1.3 million for the three months ended June 30, 2023, driven by increased sales in the Disinfection/Healthy Building Technologies segment and improved margins in the Hospitality segment.
Selling, General, and Administrative (SG&A) Expense
SG&A costs for the three months ended June 30, 2023, increased to $4.9 million as compared to $4.0 million for the three months ended June 30, 2022. The increase of approximately $0.9 million was driven primarily by the acquisitions of Puro Lighting and LED Supply Co., which accounted for an increase of approximately $1.7 million, but was offset by a reduction in other SG&A of approximately $0.7 million and a reduction in corporate expenses.
Other Expense
Other expense was $0.3 million for the three months ended June 30, 2023, which includes $0.5 million in interest expense, offset by a $0.2 million gain on the change in fair market value of contingent consideration. This compares to other expense of $0.1 million for the three months ended June 30, 2022.
Net Loss
The Company recorded a net loss of $3.0 million for the three months ended June 30, 2023, compared to a net loss of $2.9 million for the three months ended June 30, 2022. The increase in net loss of $0.1 million was mainly due to the increase in costs related to the acquisitions of Puro Lighting and LED Supply Co., offset by improved profitability in the Hospitality segment.
Total cash and equivalents as of June 30, 2023 were $3.3 million, compared to $2.7 million as of June 30, 2022.
Conference Call/Webcast Information
Applied UV’s management team will host an investor conference call and live webcast on August 21, 2023, at 9:00 am ET. Investors can access the live webcast via a link on Applied UV’s website or at https://www.webcaster4.com/Webcast/Page/2626/48955.
For those planning to participate in the call, please dial +1-888-506-(for domestic calls), or +1-973-528-0011 (for international calls), passcode 350611. A replay of the conference call will be available online on the Applied UV web site, and a dial-in replay will be available for one week following the call at +1-877-481-4010 (for domestic calls) or +1-919-882-2331 (for international calls), replay passcode 48955.
About Applied UV
Applied UV, Inc. engages in the pursuit of technologies focused on global food security, air quality, and intelligent building solutions tailored for the commercial and hospitality sectors. More details about Applied UV, Inc., and its subsidiaries can be found at https://www.applieduvinc.com.
For more on the latest developments and other exciting news, follow us on Twitter.
Forward-Looking Statements
The information contained herein may contain “forward‐looking statements.” Forward‐looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning the Company’s preliminary second quarter 2023 financial results, its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
| Applied UV, Inc. and Subsidiaries Unaudited Condensed Interim Consolidated Statements of Operations For the Three and Six Months Ended June 30, 2023 and 2022 |
||||||||||||||||
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Net Sales | $ | 10,843,686 | $ | 5,907,646 | $ | 21,498,169 | $ | 9,263,736 | ||||||||
| Cost of Goods Sold | 8,433,992 | 4,603,854 | 17,166,089 | 6,810,845 | ||||||||||||
| Gross Profit | 2,409,694 | 1,303,792 | 4,332,080 | 2,452,891 | ||||||||||||
| Operating Expenses | ||||||||||||||||
| Research and development | 180,293 | 82,049 | 369,503 | 141,363 | ||||||||||||
| Selling General and Administrative Expenses | 4,922,119 | 4,031,215 | 10,186,498 | 7,132,441 | ||||||||||||
| Loss on impairment of goodwill and intangibles | — | — | — | 1,138,203 | ||||||||||||
| Total Operating Expenses | 5,102,412 | 4,113,264 | 10,556,001 | 8,412,007 | ||||||||||||
| Operating Loss | (2,692,718) | (2,809,472) | (6,223,921) | (5,959,116) | ||||||||||||
| Other Income (Expense) | ||||||||||||||||
| Change in Fair Market Value of Warrant Liability | (1,384) | (32,111) | 918 | 11,717 | ||||||||||||
| Interest expense | (483,122) | (49,020) | (876,061) | (53,076) | ||||||||||||
| Gain (Loss) on change in Fair Market Value of Contingent Consideration | 186,000 | — | (433,999) | (240,000) | ||||||||||||
| Gain on Settlement of Contingent Consideration (Note 2) | — | — | — | 1,700,000 | ||||||||||||
| Other Income | — | 1,948 | — | 1,948 | ||||||||||||
| Total Other Income (Expense) | (298,506) | (79,183) | (1,309,142) | 1,420,589 | ||||||||||||
| Loss Before Provision for Income Taxes | (2,991,224) | (2,888,655) | (7,533,063) | (4,538,527) | ||||||||||||
| Benefit from Income Taxes | — | — | — | — | ||||||||||||
| Net Loss | $ | (2,991,224) | $ | (2,888,655) | $ | (7,533,063) | $ | (4,538,527) | ||||||||
| Net Loss attributable to common stockholders: | ||||||||||||||||
| Dividends to preferred shareholders | (407,231) | (362,250) | (769,481) | (724,500) | ||||||||||||
| Net Loss attributable to common stockholders | (3,398,455) | (3,250,905) | (8,302,544) | (5,263,027) | ||||||||||||
| Basic and Diluted Loss Per Common Share | $ | (0.77) | $ | (1.28) | $ | (2.10) | $ | (2.06) | ||||||||
| Weighted Average Shares Outstanding – basic and diluted | 4,434,036 | 2,533,077 | 3,949,211 | 2,559,957 | ||||||||||||
| Applied UV, Inc. and Subsidiaries Unaudited Condensed Consolidated Balance Sheets As of June 30, 2023 and December 31, 2022 |
||||||||
| June 30, | December 31. | |||||||
| 2023 | 2022 | |||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 3,333,544 | $ | 2,734,485 | ||||
| Accounts receivable, net of allowance for doubtful accounts | 5,049,906 | 1,508,239 | ||||||
| Costs and estimated earnings in excess of billings | 2,435,960 | 1,306,762 | ||||||
| Inventory, net | 8,207,895 | 5,508,086 | ||||||
| Vendor deposits | 1,149,385 | 75,548 | ||||||
| Prepaid expense and other current assets | 2,011,189 | 1,187,223 | ||||||
| Total Current Assets | 22,187,879 | 12,320,343 | ||||||
| Property and equipment, net of accumulated depreciation | 1,166,507 | 1,133,468 | ||||||
| Other assets | — | 153,000 | ||||||
| Goodwill | 17,809,235 | 3,722,077 | ||||||
| Other intangible assets, net of accumulated amortization | 28,000,601 | 11,354,430 | ||||||
| Right of use assets | 3,807,834 | 4,044,109 | ||||||
| Total Assets | $ | 72,972,056 | $ | 32,727,427 | ||||
| Liabilities, Redeemable Preferred Stock and Stockholders’ Equity | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | $ | 8,862,351 | $ | 2,982,760 | ||||
| Contingent consideration | 18,809,672 | — | ||||||
| Deferred revenue | 5,406,083 | 4,730,299 | ||||||
| Due to landlord (Note 2) | 189,182 | 229,234 | ||||||
| Warrant liability | 9,069 | 9,987 | ||||||
| Financing lease obligations | 41,632 | 33,712 | ||||||
| Operating lease liability | 1,689,127 | 1,437,308 | ||||||
| Notes payable, net | 4,999,257 | 2,098,685 | ||||||
| Total Current Liabilities | 40,006,373 | 11,521,985 | ||||||
| Long-Term Liabilities | ||||||||
| Due to landlord – less current portion (Note 2) | 325,557 | 393,230 | ||||||
| Notes payable, net – less current portion | 5,323,659 | 765,144 | ||||||
| Financing lease obligations – less current portion | 155,360 | 158,070 | ||||||
| Operating lease liability – less current portion | 2,190,159 | 2,655,103 | ||||||
| Total Long-Term Liabilities | 7,994,735 | 3,971,547 | ||||||
| Total Liabilities | 48,001,108 | 15,493,532 | ||||||
| Redeemable Preferred Stock | ||||||||
| Preferred Stock, Series B Cumulative Perpetual, $0.0001 par value, 1,250,000 shares authorized, 1,250,000 shares issued and outstanding as of June 30, 2023 and no shares issued and outstanding as of December 31, 2022 | 3,712,500 | — | ||||||
| Preferred Stock, Series C Cumulative Perpetual, $0.0001 par value, 2,500,000 shares authorized, 399,996 shares issued and outstanding as of June 30, 2023 and no shares issued and outstanding as of December 31, 2022 | 1,063,989 | — | ||||||
| Total Redeemable Preferred Stock | 4,776,489 | — | ||||||
| Equity | ||||||||
| Preferred Stock, Series A Cumulative Perpetual, $0.0001 par value, 1,250,000 shares authorized, 552,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 | 55 | 55 | ||||||
| Preferred Stock, Series X, $0.0001 par value, 10,000 shares authorized, 10,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 1 | 1 | ||||||
| Common Stock $0.0001 par value, 150,000,000 shares authorized 8,928,330 shares issued and 8,905,633 outstanding as of June 30, 2023 and 2,735,290 shares issued and 2,712,593 outstanding as of December 31, 2022, respectively | 893 | 274 | ||||||
| Additional paid-in capital | 56,883,253 | 45,620,764 | ||||||
| Treasury stock at cost, 22,697, respectively | (149,686) | (149,686) | ||||||
| Accumulated deficit | (36,540,057) | (28,237,513) | ||||||
| Total Equity | 20,194,459 | 17,233,895 | ||||||
| Total Liabilities, Redeemable Preferred Stock and Stockholders’ Equity | $ | 72,972,056 | $ | 32,727,427 | ||||
| Applied UV, Inc. and Subsidiaries Condensed Interim Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2023 and 2022 |
||||||||
| 2023 | 2022 | |||||||
| Cash flows from Operating Activities | ||||||||
| Net Loss | $ | (7,533,063 | ) | $ | (4,538,527 | ) | ||
| Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities | ||||||||
| Stock based compensation | 384,809 | 400,450 | ||||||
| Bad debt (recovery) expense | (135,467 | ) | 55,226 | |||||
| Change in fair market value of warrant liability | (918 | ) | (11,717 | ) | ||||
| Change in fair market value of contingent consideration | 433,999 | 240,000 | ||||||
| Gain on settlement of contingent consideration | — | (1,700,000 | ) | |||||
| Loss on impairment of goodwill and intangible assets | — | 1,138,203 | ||||||
| Amortization of right-of-use asset | 236,275 | 462,832 | ||||||
| Depreciation and amortization | 1,418,127 | 978,495 | ||||||
| Amortization of debt discount | 399,129 | 53,646 | ||||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||||
| Accounts receivable | (1,670,165 | ) | (402,965 | ) | ||||
| Cost and estimated earnings excess of billings | (595,560 | ) | (262,420 | ) | ||||
| Inventory | 1,311,288 | (2,855,073 | ) | |||||
| Vendor deposits | (698,165 | ) | 494,888 | |||||
| Prepaid expenses and other current assets | (194,044 | ) | (62,600 | ) | ||||
| Accounts payable and accrued expenses | 2,088,635 | 768,872 | ||||||
| Billings in excess of costs and earnings on uncompleted contracts | — | (616,475 | ) | |||||
| Deferred revenue | (1,622,314 | ) | 687,494 | |||||
| Due to landlord | (186,344 | ) | (93,172 | ) | ||||
| Operating lease payments | (213,125 | ) | (449,388 | ) | ||||
| Net Cash Used in Operating Activities | (6,576,903 | ) | (5,712,231 | ) | ||||
| Cash Flows From Investing Activities | ||||||||
| Cash paid for patent costs | (51,077 | ) | (682 | ) | ||||
| Purchase of machinery and equipment | (75,959 | ) | (26,043 | ) | ||||
| Acquisitions, net of cash acquired (Note 2) | (4,115,709 | ) | (10 | ) | ||||
| Payments on notes payable | (166,262 | ) | — | |||||
| Net Cash Used in Investing Activities | (4,409,007 | ) | (26,735 | ) | ||||
| Cash Flows From Financing Activities | ||||||||
| Payments on financing leases | (20,022 | ) | (3,493 | ) | ||||
| Shares repurchased | — | (149,686 | ) | |||||
| Dividends to preferred shareholders | (769,481 | ) | (724,500 | ) | ||||
| Payments on note payable | (16,438,782 | ) | — | |||||
| Proceeds from equity raises, net | 6,630,799 | 1,092,000 | ||||||
| Proceeds from note payable, net | 22,182,455 | — | ||||||
| Net Cash Provided by Financing Activities | 11,584,969 | 214,321 | ||||||
| Net Increase (Decrease) in Cash and equivalents | 599,059 | (5,524,645 | ) | |||||
| Cash and cash equivalents at January 1, | 2,734,485 | 8,768,156 | ||||||
| Cash and cash equivalents at June 30, | $ | 3,333,544 | $ | 3,243,511 | ||||
| Supplemental Disclosures of Cash Flow Information: | ||||||||
| Cash paid during the year for: | ||||||||
| Interest | $ | 308,955 | $ | 4,102 | ||||
| Supplemental Non-Cash Disclosures of Investing and Financing Activities | ||||||||
| Conversion of debt into common stock | $ | 217,500 | $ | — | ||||
| Recognition of right of use asset and corresponding lease liability | $ | 563,315 | $ | 1,380,658 | ||||
For Additional Company Information:
Applied UV, Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…